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Introduction: Does the endometrial thickness (EMT) at the time of follicle aspiration
correlate with the pregnancy rate in unstimulated menstrual cycles?
Materials and Methods: This is a retrospective, observational single center study.105
women with regular menstrual cycles undergoing their first NC-IVF cycle with an embryo
transfer were analyzed. Clinical pregnancy and live birth rates were calculated and data
were adjusted for women’s age, cycle day of follicle aspiration and body mass index
(BMI).
Results: Age of participants was 35.0 y [32.0; 37.0]. Follicle aspiration was performed on
day 14.0 [12.0; 15.0] of the cycle. Total clinical pregnancy rate was 24.8% and live birth
rate 15.2% per transfer. Pregnancy rate in women with endometrial thickness ≤7mm
(n = 27) was 7.4 and 30.8% in women >7mm (n = 78) (OR 5.56, 1.22–25.36) (P
= 0.03). Live birth rates were not significantly different. Quadratic regression analysis
revealed lower pregnancy rates in women with thin (around <8mm) as well as with thick
(around>11mm) endometria. P-value after crude quadratic analysis was 0.028 and after
adjustment for age, day of aspiration and BMI was 0.039. Significance was not reached
for live birth rates.
Conclusion: Thin endometrium should also be considered as an independent negative
prognostic factor for achieving pregnancy in women without ovarian stimulation.
Keywords: endometrium, pregnancy rate, live birth rate, natural cycle IVF, spontaneous cylce
INTRODUCTION
The importance of the endometrium for the development and maintenance of pregnancy is
clearly proven. However, it is unclear which endometrial factors are of relevance (1). Histological
examination in couples who wish to conceive makes little sense as a biopsy would be necessary.
In transvaginal ultrasound evaluation endometrial thickness, the echo pattern and endometrial
perfusion are evaluated (2). Ultrasound analysis of endometrial thickness (EMT) is most commonly
performed, as this is the easiest and best reproducible technique.
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The significance of the endometrial thickness has been
investigated in numerous studies and in meta-analyses. The
investigations are essentially limited to in vitro fertilization
treatments (IVF) with high-dose stimulation therapy and
intrauterine insemination treatment (IUI) with different ovarian
stimulation regimes.
In IVF treatments, a thin endometrium is associated with
lower pregnancy rates. The clinical pregnancy rate is related
to a lower chance of pregnancy if endometrial thickness is
≤7mm (OR 0.42, 95% CI: 0.27, 0.67) (3). The data regarding a
thick endometrium is not so clear. A previous study described
reduced pregnancy rates in women with endometrium >14mm
(4), whereas other studies did not find decreased or found even
increased pregnancy rates (5–7).
In women undergoing IUI with low dose stimulation, such a
relationship does not appear to exist. In a recent meta-analysis
with IUI treatments combined with a gonadotrophin, clomifene
citrate, or aromatase inhibitor stimulation, there was no evidence
of a difference in EMT between women who conceived and
women who did not conceive (MDrandom: 0.51, 95% CI: −0.05,
1.07) (8).
Because ovarian stimulation treatments were used, the results
of these studies cannot be transferred to the unstimulated
situation. As a result, the study findings have only limited use
in a fertility work-up for infertility to assess the relevance of the
endometrium as a cause of sterility.
Based on this, we investigated the pregnancy rate as a function
of the endometrial thickness using the Natural Cycle IVF (NC-
IVF) model, in which no ovarian stimulation except ovulation
induction with human chorionic gonadotropin, hCG, and luteal
phase progesterone supplementation was administered.
Since strict inclusion and exclusion criteria such as the
transfer of only one embryo were defined and thus numerous
confounders on the pregnancy rate could be excluded, this may
be the first study which also allows a cautious estimate of the
importance of endometrial thickness for a pregnancy event in a
spontaneous cycle.
METHODS
Study Population and Participants
The retrospective, observational single center study was
performed between 2011 and 2016. A total of 225 women, 18–42
years of age with regular menstrual cycles (24–32 days) and
basal FSH concentrations <10 IU/L undergoing their first IVF
cycle treatment with transfer of a single embryo were screened.
Women had been offered both, NC-IVF and conventional IVF
but decided themselves which therapy they preferred. Women
without a transfer, with endometriosis >rAFS II◦ (revised
American Fertility Society) (as diagnosed by laparoscopy or
clinical and ultrasound analysis), with fibroids as diagnosed
by ultrasound or in case ultrasound was not conclusive by
hysteroscopy and with sperm collection by testicular sperm
extraction (TESE) were excluded.
NC-IVF patients were monitored using ultrasound and
analysis of luteinizing hormone (LH) and E2 concentrations.
When the follicle diameter reached at least 18mm and the E2-
concentration was expected to be ≥800 pmol/L, 5000 IU of
hCG (Pregnyl R©, MSD Merck Sharp & Dohme GmbH, Lucerne,
Switzerland) were administered and patients were scheduled 36 h
later for oocyte retrieval. EMT was measured at the time of
oocyte aspiration by different physicians and different ultrasound
machines. Endometrium thickness was measured in mmwithout
decimal numbers in our clinical routine as intraindividual
and interindividual variations did not justify a more precise
measurement. Follicles were aspirated without anesthesia and
without analgesia using 19G single lumen needles (220 mmHg)
as described elsewhere (9). After aspiration, follicles were flushed
and aspirated 3 times each using 2–5ml flushing medium
with heparin (SynVitro
R©
Flush, Origio, Berlin, Germany). The
flushing volume was adapted according to the size of the follicles.
Fertilization was achieved by standard ICSI in all cases. Embryos
were transferred on day 2 or 3 after aspiration as long term
culture was not required with only one embryo. Women received
luteal phase support with vaginal micronized progesterone. EMT
at the time of follicle aspiration as well as biochemical and clinical
(defined as ultrasound detection of an amniotic sac) pregnancy
rates and live birth rate were analyzed per embryo transfer.
The study was carried out in accordance with the
recommendations of the local ethical committee of the IRB
Internal Review Board, Inselspital Bern on October 12th 2012
(IRB 12–223). All subjects gave informed written consent in
accordance with the Declaration of Helsinki.
Statistical Analysis
Endometrial thickness was first considered as a categorical
variable and therefore women were divided into two endometrial
thickness groups (≤7mm vs. >7mm). Patients’ baseline
characteristics were compared for quantitative variables by using
the t-test, or if normality assumption was not satisfied, by non-
parametric Wilcoxon-test. For qualitative variables (cause of
infertility), the Chi-square test was used or by Fisher’s exact test
when the sample size was small.
Clinical pregnancy and life birth rate where compared using
a logistic regression. For each outcome, we first assessed the
crude (unadjusted) association between EMT categories and the
outcome. We then adjusted the model for potential confounders
by including women’s age, day of follicle aspiration and BMI
in the model. The cause of the infertility was not considered
as we had been shown in another, not yet published, study,
that the cause of infertility is not a prognostic factor in NC-
IVF. Endometrial thickness was then considered as a continuous
variable and its effect on pregnancy and on live birth was further
analyzed using logistic regression. For each outcome, we first
assessed the crude (unadjusted) and adjusted association between
EMT and the outcome, using endometrial thickness as a linear
term. Then, we examined the linearity of the effect of EMT on
the outcomes by fitting a crude and adjusted quadratic regression
model and by testing whether the addition of a quadratic
term significantly increased the fit of the model. Models were
compared using likelihood ratio tests. P-value and the confidence
interval of models parameters were estimated using the normal
approximation.
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RESULTS
Two hundred and twenty five women undergoing a NC-IVF
cycle were identified. One hundred and eleven women (49.3%)
were excluded due to missing transfer (premature ovulation 14%,
aspirations without oocyte 15%, oocytes without fertilization
or arrested embryo growth 16%), 5 women (2.2%) due to
endometriosis, and 4 women (1.8%) due to TESE, resulting in 105
women to be included in the analysis. Cycles and transfers were
not canceled due to thin endometrium. The basic characteristics
of these women are shown in Table 1. Age of participants was
35.0 y [32.0; 37.0], cycle day of follicle aspiration was 14.0
[12.0; 15.0] and duration of infertility was 3.00 y [2.00; 4.00].
Infertility factors were severe male factor (sperm < 5 Mill/ml)
(n = 26, 24.8%), moderate and mild male factor (sperm 5- <
15 Mill/ml or total motility <40%) (n = 24, 22.9%), tubal factor
(peritubal adhesions, blockage of one or both fallopian tubes),
endometriosis rAFS I-II◦ and mixed factors (n= 22, 21.0%), and
idiopathic infertility (n= 33, 31.4%).
Overall AMH concentrations were 12.0 pmol/l [6.0; 22.0].
Clinical pregnancy rate and live birth rate as a function of
endometrial thickness are shown in Figures 1, 2. Endometrial
thickness was 6mm in 6 women, 7mm in 21, 8mm in 31, 9mm
in 17, 10mm in 15, 11mm in 9, 12mm in 5, and 16mm in 1
woman.
The pregnancy rate was firstly compared in women with
endometrial thickness ≤7mm (n = 27) vs. >7mm (n = 78).
The groups did not differ regarding women’s age, cycle day of
aspiration, duration of infertility, BMI and cause of infertility
(Table 1). Clinical pregnancy rates in women with endometrial
thickness ≤7mm (n = 27) vs. >7mm (n = 78) were 7.4 and
30.8%, respectively.
Crude and adjusted logistic regression, adjusted for women’s
age, day of follicle aspiration and BMI, showed an increased
odds of pregnancy in patients with increased endometrial
thickness >7mm (crude OR 5.56, 95% CI: 1.22–25.36, p =
0.027; adjusted OR 5.50, 95% CI: 1.14–26.62, p = 0.034).
Likewise, the odds of live birth was also increased in patients
with increased endometrial thickness, however, associations
were not significant (crude OR 6.19, 95% CI: 0.78–49.27,
p = 0.085; adjusted OR 5.98, 95% CI: 0.74–48.56, p =
0.094).
We also used endometrial thickness as a continuous variable
in logistic models. There is a not significant trend of a linear
relationship between continuous endometrial thickness and
pregnancy [crude OR (per log (mm)): 6.63, 95% CI: 0.61–71.99,
P = 0.12]; adjusted OR [per log (mm)): 4.52, 95% CI: 0.38–
53.14, P = 0.23]. Likewise, there is a non-significant trend
of a linear, non-significant relationship between continuous
endometrial thickness and live birth [crude OR (per log (mm)):
8.99, 95% CI: 0.54–150.06, P = 0.13]; adjusted OR [per log
(mm)): 8.02, 95% CI: 0.41–157.41, P = 0.17]. However, the
model fit is better whenmodeling a quadratic relationship instead
of a linear relationship between endometrial thickness and
clinical pregnancy (p-value from a model comparison = 0.03).
The crude and adjusted quadratic models indicate a decreased
odds of pregnancy for thinner (around <8mm, n = 27) but
also for very thick (around >11mm, n= 5) endometrium (p-
value for quadratic relationship: crude p = 0.028; adjusted p =
0.039).
Likewise, there was also a trend of a better model fit when
modeling a quadratic relationship between endometrial thickness
and live birth (p-value from a model comparison = 0.08). The
crude and adjusted quadratic models indicate a decreased odds
of pregnancy for thinner but also for very thick endometrium (p-
value for quadratic relationship: crude p = 0.066; adjusted p =
0.093).
DISCUSSION
Main Findings
This study described for the first time the association of
pregnancy rates with endometrial thickness in unstimulated
menstrual cycles with fresh embryo transfers. The evaluation was
adjusted for the main factors that could influence the chance of
pregnancy (age) (10) and the EMT (day of aspiration and BMI)
(11).
Strengths and Limitations
To minimize the influence of possible influencing variables,
the investigation was carried out using 105 NC-IVF cycles,
in which–as in almost all NC-IVF cycles–only one embryo
was transferred. Different numbers of embryos would not have
allowed a comparison of pregnancy rates. However, it needs to be
noted that first we performed a retrospective analysis and second
that the strict inclusion and exclusion criteria resulted in a limited
number of participants. This might be a reason why significance
was only reached for pregnancy but not for live birth rate.
Endometrium thickness was analyzed by several physicians
using different ultrasound machines. Therefore, and due
to the intra und interindividual variations of endometrial
measurements, EMT was analyzed without decimal numbers,
which could have affected the precision of the analysis.
We defined the ultrasound detection of an amniotic sac as
a clinical pregnancy, which might explain the high miscarriage
rate. However, the miscarriage rate could not be allocated to a
specific endometrial thickness.
Interpretation
In all studies published to date, the association of endometrial
thickness with pregnancy rate was performed only with high-
dose IVF stimulations, cryopreserved embryos (12) or low-dose
IUI stimulations. The IVF studies suggested an increase in the
pregnancy rate with an endometrium >7mm (3), whereas the
IUI studies failed to demonstrate such a relationship (8). Our
study confirmed the reduced pregnancy rate in gonadotrophin-
stimulated IVF therapies with an endometrial thickness of
≤7mm. However, an increase in the pregnancy rate in a
particularly thick endometrium of >11mm (6), >13mm (5),
or >14mm (7), as demonstrated with gonadotrophin-stimulated
IVF therapies, could not be confirmed. In contrast, we even
observed a tendency to lower pregnancy rates in women with
particularly thick endometrium. In IUI treatments with low dose
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TABLE 1 | Baseline characteristics of all analyzed patients (n = 105) and of women with endometrial thickness ≤7mm (n = 27) vs. >7mm (n = 78) (data are shown as
median and upper and lower quartile ranges).
Total (n = 105) EMT ≤7mm (n = 27) EMT >7mm (n = 78) P-value
Age at time of aspiration
(years)
35.0
(32.0; 37.0)
37.0
(33.5; 39.5)
34.0
(32.0; 36.0)
0.06
Cycle day of follicle aspiration 14.0
(12.0; 15.0)
14.0
(13.0; 15.0)
14.0
(12.0; 15.0)
0.46
Infertility since
(years)
3.00
(2.0; 4.0)
3.0
(2.0; 3.0)
3.0
(2.0; 4.0)
0.41
Body mass index, BMI 21.3
(20.0; 23.4)
20.8
(19.2; 22.3)
21.6
(20.2; 23.5)
0.13
Cause of infertility (n, %) 0.98
Severe male factor 26(24.8%) 7(25.9%) 19(24.4%)
moderate/mild male factor 24(22.9%) 6(22.2%) 18(23.1%)
Tubal factor, endometriosis rAFS
I-II◦ and mixed factors
22(21.0%) 5(18.5%) 17(21.8%)
Idiopathic 33(31.4%) 9(33.3%) 24(30.8%)
Thickness of the endometrium(mm) 8.0
(7.0; 10.0)
7.0
(7.0; 7.0)
9.0
(8.0; 10.0)
Not
applicable
FIGURE 1 | Clinical pregnancy (not hatched) and live birth (hatched) rates as a function of endometrial thickness. The bar width is proportional to the number of
women in each category.
gonadotrophin stimulation, neither an increased nor a reduced
pregnancy rate (8) was found.
The reason for the reduced pregnancy rates in patients
undergoing gonadotrophin-stimulated IVF therapies with an
endometrial thickness ≤7mm compared to an endometrial
thickness >7mm is unclear. It has been speculated
that basal layer endometrial oxygen concentrations are
increased in patients with a thin endometrium, which
might be detrimental for embryo implantation (13).
It was further speculated that embryos developing in
vitro are especially susceptible to this higher oxygen
exposure (8).
In hormone-stimulated IUI treatments, there is no significant
correlation between the endometrial thickness and the pregnancy
rate (8). As a possible reason for this, it was discussed that
embryos develop more robustly in vivo and are less susceptible
to high oxygen exposure (8). However, this explanation is purely
hypothetical. Therefore, it could be speculated that in hormone-
stimulated IUI treatments a thin endometrium is associated with
lower pregnancy rates, but that this association could not be
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FIGURE 2 | Clinical pregnancy rate (not hatched) and live birth (hatched) rates in women with endometrial thickness ≤7mm vs. >7mm. The bar width is proportional
to the number of women in each category.
detected. In the meta-analysis by Weiss et al. (8), the primary
analysis showed a significantly thinner endometrium in women
who did not conceive (MD: 0.48, 95% CI: 0.18, 0.77). The
significance was only lost when the calculation was performed
using a random effects model (MD random: 0.51, 95% CI:−0.05,
1.07) which was chosen due to the heterogeneity of studies.
This raises the question of whether a thin endometrium is
also associated with lower pregnancy rates in stimulated IUI
treatments; however, this association could not be detected due
to the heterogeneity across the studies.
Pregnancy rates have also been studied in modified natural
cycles with frozen-thawed embryo transfers (12). Mean
endometrial thickness did not differ between patients achieving
ongoing pregnancy and those who did not. However, the
pregnancy rates in women with endometrium of <7mm (n =
41) was only 9.8% whereas in women with an endometrium
of ≥7mm it was 21.0% (12). Even though the differences were
not statistically different, these data support the hypothesis, that
pregnancy rates are lower in women with thin endometrium,
even in unstimulated cycles.
Lower pregnancy rates with a thin endometrium in
unstimulated cycles are unlikely to be biologically plausible. It
is unlikely that a tendency toward a thin endometrium could
be inherited if it significantly affected fertility. There are, of
course, numerous factors that lead to a thin endometrium or
which are associated with a thin endometrium and lower the
chances of pregnancy. The most relevant factors are multiple
curettages (14) and exposure of the uterus to radiation (15).
However, these factors are either iatrogenic or due to an acquired
pathology and therefore cannot explain the reduced pregnancy
rates with a thin endometrium as described in other studies. In
our study only 1/6 (16.7%) of the women with an endometrial
thickness of 6mm and 4/21 (19.0%) with an endometrial
thickness of 7mm had undergone a curettage and none an
uterine radiation. Accordingly a curettage could be a reason for a
thin endometrium is a few women but not in the majority.
On the other hand, the question arises of how relevant a
reduced pregnancy rate with a thin endometrium really is. Of
the 6 non-pregnant women in our study with an endometrial
thickness of 6mm, 3 women became pregnant later on. Thus, the
clinical relevance of a thin endometrium without a recognizable
cause such as multiple curettages etc., is questionable.
If a patient’s endometrium is very thin, and if this may
be a possible cause of infertility, the question of possible
therapeutic options arises. Stimulation with estrogens can hardly
be carried out in a spontaneous cycle, since high estrogen
concentrations reduce FSH release and inhibit folliculogenesis
and also impair endometrial function (16). Santamaria et al. (17),
developed a treatment with bone marrow-derived stem cells,
which seems to increase the chances of pregnancy in refractory
Asherman’s syndrome and endometrial atrophy. Whether such
a complex and still experimental therapy is useful in cases with
physiologically thin endometrium is questionable, since in such
cases the endometrium is thinner but presumably functionally
intact.
The differences in studies regarding the effect of a thick
endometrium on the pregnancy rate are contradictory. In the
gonadotrophin-stimulated IVF studies, a thick endometrium
appears to be associated with a higher pregnancy rate (5–
7). However, such a dependence could not be demonstrated
in hormone-stimulated IUI therapies (8). We even found a
tendency toward a reduced pregnancy rate. However, it needs to
be noted that this finding is based on a statistical model which
only provides a very vague tendency toward a lower pregnancy
rate with very thick endometrium. Furthermore, the thickness
which leads to decreased pregnancy rates cannot be defined.
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The differences of the studies are barely explainable. It possibly
concerns physiologically different endometrial function and IVF
activity states, which do not allow a comparison of the different
treatments as the endometrium is likely to be more proliferated
and oedematous with gonadotrophin stimulation. It is also
possible that the differences are due to the low number of patients
in our study which can be considered a weakness of our study.
Since the inclusion and exclusion criteria were very strict to
be able to examine a patient population as homogeneously as
possible, the patient numbers are limited.
In conclusion, the study confirmed that thin endometrium
is also associated with lower pregnancy rates in unstimulated
cycles. Therefore, thin endometrium should be regarded as an
independent prognostic factor for achieving a pregnancy.
However, as the pregnancy rate in women with thin
endometrium is not zero but only reduced, thin endometrium
should not be regarded as an infertility but rather as a
fertility-reducing factor.
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